Efficacy, safety of and adherence to adjustable compression wraps in the control phase of breast cancer-related lymphedema: A randomized controlled trial
Clinical Rehabilitation · 2024
DOI: 10.1177/02692155241270921 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Rehabilitation, 2024. Verfasst von Jéssica Malena Pedro da Silva und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil. Hauptthemen laut MEDLINE: Compression Bandages, Breast Cancer Lymphedema, Patient Compliance, Quality of Life. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: VENOSAN BRASIL LTDA, Instituto Nacional do Câncer, Ministério da Saúde.
Abstract (Originalsprache)
Objective
To evaluate efficacy, safety, and adherence to using adjustable compression wraps (ACWs) for upper limb volume control in women with breast cancer-related lymphedema. Design and Setting Randomized controlled trial at a reference hospital for breast cancer treatment in Brazil.
Participants
Women in control phase of the breast cancer-related lymphedema.
Interventions
Compared use of ACWs versus compressive mesh. Main Measures Evaluated before treatment, at 30 days, and 6 months after initiating therapy. The primary outcome was the change in excess limb volume. Secondary outcomes included adherence, incidence of adverse events, functionality, quality of life, and hand grip. Statistical analysis involved calculating the effect size (ES) with a 95% confidence interval.
Results
Were included 71 women with mean excess limb volume of 321.79 mL (±194.98). In the 30-day analysis (Time 1), a reduction of 37.6 mL in volume was observed only in the ACW group ( p = .041, ES 0.20), with improved functionality ( p = .013, ES 0.22). In the six months analysis (Time 2), the compressive mesh group increased by 2.48% in volume ( p = .023, ES 0.26) and demonstrated improvement functionality ( p = .036, ES 0.27). Mild adverse events and satisfactory adherence were observed. However, in the intergroup comparison, no statistically significant difference was observed for any evaluated outcome—excess volume, incidence of adverse events, adherence, hand grip, quality of life, and functionality between the groups ( p > .05) at both times.
Conclusions
Both compression therapies achieved satisfactory adherence, were safe, effective and equivalent for controlling limb volume in breast cancer-related lymphedema.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil.
- Hospital Cancer III, Brazilian National Cancer Institute (INCA), Rio de Janeiro, RJ, Brazil.
- Institute Celulare, Rio de Janeiro, RJ, Brazil.
ORCID-Profile: Jéssica Malena Pedro da Silva, Anke Bergmann
Förderung
- VENOSAN BRASIL LTDA
- Instituto Nacional do Câncer, Ministério da Saúde
Zitieren
APA
Silva, J. M. P. D., Araújo, R. D. D., Aguiar, S. S., Fabro, E. A. N., Pinto, M. V. M., Thuler, L. C. S., & Bergmann, A. (2024). Efficacy, safety of and adherence to adjustable compression wraps in the control phase of breast cancer-related lymphedema: A randomized controlled trial. Clinical Rehabilitation. https://doi.org/10.1177/02692155241270921
Vancouver
Silva JMPD, Araújo RDD, Aguiar SS, Fabro EAN, Pinto MVM, Thuler LCS, et al. Efficacy, safety of and adherence to adjustable compression wraps in the control phase of breast cancer-related lymphedema: A randomized controlled trial. Clinical Rehabilitation. 2024. doi:10.1177/02692155241270921
BibTeX
@article{Silva2024,
author = {Silva, Jéssica Malena Pedro da and Araújo, Raul Denner Duarte and Aguiar, Suzana Sales de and Fabro, Erica Alves Nogueira and Pinto, Marcus Vinicius de Mello and Thuler, Luiz Claudio Santos and Bergmann, Anke},
title = {Efficacy, safety of and adherence to adjustable compression wraps in the control phase of breast cancer-related lymphedema: A randomized controlled trial},
journal = {Clinical Rehabilitation},
year = {2024},
doi = {10.1177/02692155241270921}
}
EUVIMED